OPTOMICS Clinical Trial

The OPTOMICS project includes a clinical trial, with two investigation sites: one at the university hospital (Klinikum rechts der Isar) of the Technical University of Munich (TUM) , and one at the University of Tartu in Estonia. The aim of the study is to investigate changes in microvascular structure and function in the skin in patients with (and without) type-2 diabetes mellitus using a novel non-invasive optoacoustic imaging method (RSOM) combined with molecular phenotyping. Both clinical trials have been approved by their relevant Ethics Committees and regulating bodies at the local and federal levels.

We are currently actively recruiting participants aged 40 to 90 with and without type-2 diabetes for the study in Munich. If you are interested in participating, please read the recruitment flyer below for details and contact us with the form below.

Wir rekrutieren derzeit aktiv Teilnehmer im Alter von 40 bis 90 Jahren mit und ohne Typ-2-Diabetes für die Studie in München. Wenn Sie an einer Teilnahme interessiert sind, lesen Sie bitte den untenstehenden Rekrutierungsflyer und kontaktieren Sie uns mit dem untenstehenden Formular.

Contact Form

Submitting this form is non-binding and does not constitute enrollment in the study.

Join our mailing list